Justin Anglin

Title: Justin Anglin: Innovator in Bacterial Infection Treatment

Introduction

Justin Anglin is a notable inventor based in Houston, Texas. He has made significant contributions to the field of medicine, particularly in the treatment and prevention of bacterial infections. His innovative work focuses on developing compounds that can effectively inhibit harmful enzymes.

Latest Patents

Justin Anglin holds a patent for "Compounds and methods for treating or preventing bacterial infections." This patent relates to compounds that can inhibit β-lactamases, including OXA enzymes such as OXA-24, OXA-48, and OXA-58. These compounds are designed to inhibit the activity of β-lactamases both in vitro and in vivo, showcasing their potential in medical applications. He has 1 patent to his name.

Career Highlights

Justin Anglin is affiliated with the Baylor College of Medicine, where he continues to advance his research and innovations. His work is crucial in addressing the growing concern of antibiotic resistance, making his contributions highly relevant in today's medical landscape.

Collaborations

Throughout his career, Justin has collaborated with esteemed colleagues such as Timothy Palzkill and Doris Taylor. These partnerships have further enriched his research and expanded the impact of his inventions.

Conclusion

Justin Anglin's work in developing compounds to combat bacterial infections highlights his role as an important inventor in the medical field. His innovative approaches are paving the way for new treatments that could significantly improve patient outcomes.